Structured evidence table for Valerian Sleep Latency Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Valerian Sleep Latency Randomized Trial | This comprehensive review critically examines contemporary advances in understanding the mechanistic actions of natural products against insomnia and their supporting clinical evidence, with the objective of synthesizing their pharmacological mechanisms, clinical effectiveness, and safety evaluations. | 3 | Ma D (2026) | Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review. |
| Valerian Sleep Latency Randomized Trial | Critically, clinical evidence confirms these natural products treatment outcomes with favorable safety profiles in insomnia management. | 3 | Ma D (2026) | Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review. |
| Valerian Sleep Latency Randomized Trial | Conclusion This review critically evaluates contemporary advances in botanical therapeutics for insomnia management, synthesizing evidence to inform evidence-based clinical translation and facilitate the development of novel pharmacotherapeutic strategies. | 3 | Ma D (2026) | Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review. |
| Valerian Sleep Latency Randomized Trial | Background Insomnia, a prevalent sleep disorder, adversely impacts patients' quality of life and imposes significant burdens on both physical and mental health. | 3 | Ma D (2026) | Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review. |
| Valerian Sleep Latency Randomized Trial | Failure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Valerian Sleep Latency Randomized Trial | While both the quantity and the quality of sleep can be largely improved with relatively straightforward practices dictated by good sleep hygiene, emerging research suggests that dietary and supplementation protocols focused on certain foods, nutrients, and biochemical compounds with sleep-promoting properties can act as subsidiary sleep aids in complementing these behavioral changes. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Valerian Sleep Latency Randomized Trial | The scope of this narrative review is to summarize the available evidence on the potential benefits of selected nutraceuticals in the context of circadian rhythm and sleep disturbances, namely melatonin, magnesium, omega-3 fatty acids, tart cherry juice, kiwifruit, apigenin, valerian root, L-theanine, glycine, ashwagandha, myoinositol, Rhodiola rosea, and phosphatidylserine. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
| Valerian Sleep Latency Randomized Trial | Humans spend approximately one third of their life asleep but, as counterintuitive as it may sound, sleep is far from being a quiet state of inactivity. | 4 | Conti F (2026) | Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. |
Source documents